Ultrasound-guided transhepatic radiofrequency ablation of renal tumors: A safe and effective approach

Ryan M. Hegg, Grant D. Schmit, A. Nicholas Kurup, Adam J. Weisbrod, Stephen A. Boorjian, Thomas D. Atwell

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Purpose: This study was designed to determine the feasibility and safety of ultrasound-guided transhepatic radiofrequency ablation (RFA) of masses in the right kidney. Methods: Between June 2001 and December 2011, 18 patients who underwent transhepatic renal RFA procedures to treat 19 tumors were retrospectively identified. Complications (Clavien-Dindo classification system) and local tumor control were evaluated for all patients. Results: Median maximal diameter of the treated renal tumors was 1.9 (range 1.1-4.3) cm. No major complication developed during any of the procedures. No hepatic tumor seeding was identified during imaging follow-up. There was a single technical failure (5.3 %). Median cross-sectional imaging follow-up was 28 (range 3-121) months. Primary technique failure (local recurrence) occurred in 1 of the 16 tumors with follow-up imaging (5.3 %). Conclusions: Percutaneous ultrasound-guided transhepatic RFA of renal neoplasms is technically feasible, effective, and associated with a low rate of complications. The transhepatic approach may allow safe ablation of renal tumors that would otherwise be difficult to treat.

Original languageEnglish (US)
Pages (from-to)508-512
Number of pages5
JournalCardiovascular and Interventional Radiology
Issue number2
StatePublished - Apr 2014


  • Ablation
  • Clinical practice
  • Interventional oncology
  • Non-vascular interventions
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Ultrasound-guided transhepatic radiofrequency ablation of renal tumors: A safe and effective approach'. Together they form a unique fingerprint.

Cite this